Indication And Usage

significant tumor response to Cytodrox has been demonstrated in melanoma, resistant chronic myelocytic leukemia, and recurrent, metastatic, or inoperable carcinoma of the ovary.
Cytodrox used concomittently with irradiation therapy is intented for use in the local control of primary squamous cell (epidermoid) carcinomas of the head and neck, excluding the lip.